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Chapter 1 Iron, sulphur and iron-sulphur cluster 
biogenesis 
1.1 Introduction 
Trace elements constitute only 0.15% of the mass of the human body; yet, 
more than a dozen of them are indispensable for sustaining life in a cell. Iron is one 
such vital trace element. In humans, approximately 50-60% of this iron is a 
constituent of haemoglobin. The remaining iron is incorporated in the cell’s ferritin 
reserves by means of haemoglobin recycling and distributed intracellularly when 
required [2]. Iron, being a natural electron acceptor or electron donor, is highly 
reactive and hence, in its free form is extremely toxic to the cell. Any imbalance in 
human iron metabolism leads to iron deficiency or iron overload and triggers the 
release of free iron. These possibilities are witnessed through the pathophysiology of 
diseases like Friedreich’s ataxia, ISCU myopathy, a rare form of sideroblastic anemia 
and Respiratory complex I-associated encephalomyopathy (where iron accumulation 
is a common feature) and, Anemia (where iron deficiency is the cause) [3].  
Another reactive species critical for the survival of a human cell is sulfur and 
it is of significance because it readily forms bonds with iron and other trace 
elements. Sulfur reserves in the body are slightly higher than iron reserves as it 
constitutes the list of elements that make up 0.85% of the human body mass. Of the 
available non-metals in the body, sulfur is only next to phosphorus in its versatility of 
reactivity. This makes sulfur an integral part of many vital proteins, carbohydrates, 
cofactors and metabolites. Consequently, sulfur needs to be regulated through 
sulphur metabolism. A human cell acquires sulphur in the form of the amino acids - 
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cysteine and methionine, and any imbalance in sulphur metabolism would lead to 
sulphur overload or sulphur deficiency. However, the effects of sulphur overload are 
not prominent in any diseased state because the human body has an efficient 
mechanism to excrete sulfur in the form of sulphate through urine, unlike iron that 
does not have a physiological mechanism to eliminate excess iron[4]. In contrast, 
sulfur deficiency has multiple side effects on human physiology. When methionine is 
depleted, the transsulfuration pathway for cysteine biosynthesis and 
transmethylation pathway for homocysteine biosynthesis is affected[5]. Cysteine’s 
bioavailability depends entirely on methionine intake, the depletion of which causes 
oxidant stress due to glutathione (a tripeptide antioxidant containing cysteine) and 
taurine (antioxidant) inadequacy[6]. Intestinal villus atrophy and low intestinal crypt 
depth due to limited cell proliferation and high apoptosis (oxidant stress-associated) 
are therefore, symptoms of methionine deficiency [6].  
Owing to the reactivity of these two chemical species, one would be tempted 
to wonder what they could form in each other’s company and whether this 
complexation would be beneficial to the human cell in any way. This brings us to the 
exciting field of iron-sulfur cluster chemistry. Infact, it appears as though nature has 
evolved an elegant mechanism, by allowing iron sulfur cluster (or Fe-S clusters) 
formation, to circumvent the problems arising from free iron and free sulfur 
reactivity in the cell.    
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1.2 Background 
Until the mid-60s iron was believed to be a cofactor in all iron-containing 
proteins. Simple spectral studies which were performed previously had 
demonstrated that some of these proteins had extinction coefficients lower than 
heme proteins at around 400nm[7]. With the development of Infrared spectroscopy, 
Mossbauer spectroscopy, EPR and ENDOR spectroscopy, these intriguing iron-
containing proteins were found to be actually iron-sulfur proteins[8], and they 
constituted such a vital cohort of proteins that they could not be ruled out as 
‘exceptions’. Structurally, these proteins could accommodate clusters in the form of 
2Fe-2S, 3Fe-3S, 3Fe-4S, 4Fe-4S, 8Fe-7S and 8Fe-8S. To add to their diversity, these 
clusters could exhibit different redox states like [2Fe-2S]2+, [2Fe-2S]+, [3Fe-4S]2+, 
[3Fe-4S]+, etc.[8] Some of these proteins were found to house more than one type of 
cluster; others could house one Fe-S cluster and metal ions. This structural diversity 
constituted by diverse Fe-S protein folds and its link with protein stability is an 
emerging field in coordination chemistry[9].    
Individually, these iron sulfur clusters could be produced in vitro and like their 
precursors were found to be extremely versatile. They were originally thought to be 
“sensitive” molecules as they degraded in the presence of dioxygen. This notion 
changed when methods using mild denaturants and carrier thiols were designed to 
extrude these clusters from different apoproteins[10]. They were also remarkably 
capable of conversion and interconversion in both the free and protein-bound 
conditions [10].This meant that they could swap cysteine ligands in proteins with or 
without cluster conversion. In the protein-bound form, they could facilitate substrate 
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activation (Aconitase), electron transfer (Respiratory complexes I, II, III), 
environmental oxygen sensing (Fumarate-Nitrate Reduction protein), DNA repair 
(Base excision repair glycosylases), ribosome assembly (ABCE1 protein), DNA-RNA 
processing (helicases, DNA polymerases, telomere length regulator proteins), tRNA 
thiolation and even, iron regulation (iron regulatory protein). This exemplifies their 
usefulness in most of the life sustaining phenomena inspite of constituting only a 
tiny fraction of the human body mass. Researchers have also identified diseases 
associated with Fe-S clusters. A list of diseases for Fe-S clusters is provided in Table 
1. For its tremendous influence on myriad pathways, it would be surprising if we did 
not witness these iron-sulfur clusters in the most primitive life forms on earth. 
Today, they offer excellent cues to predict the molecular basis of the origin of life 
and reaffirm the concepts of evolution[11].  
Despite these major breakthrough discoveries about their nature, their 
reactivity, their distribution and their usefulness, one prominent question remained, 
‘Were these clusters made in the cell or were they acquired from the external 
environment?’. It took the scientific community another thirty years for this question 
to be answered when Dean and co-workers identified a set of nif genes whose 
proteins were found to participate in cluster formation for the Nitrogenase enzyme 
in A.vinelandii[12]. The puzzle was solved and slowly key players of this process were 
uncovered one by one!   
1.3 Cell-specific differentiation of the pathway 
Today, we know that prokaryotes have three different pathways for iron 
sulfur cluster biogenesis; whereas, eukaryotes have two different iron-sulfur cluster  
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Human protein Function Associated disease 
Biogenesis components 
Mitoferrin Putative iron 
transporter 
Erythropoietic protoporphyria 
ISCU Mitochondrial 
scaffold 
Myopathy with exercise intolerance 
Frataxin Iron donor for ISCU 
scaffold 
Friedreich’s ataxia 
GLRX5 Transfer of Fe-S 
cluster from ISCU to 
apoprotein 
Microcytic anaemia 
ADR Electron transfer Tumor suppressor 
ABCB7 (Atm1 
homolog) 
ISC export machinery 
component, ABC 
transporter 
X-linked sideroblastic anaemia and 
cerebellar ataxia 
Fe-S proteins 
Complex I Complex I of 
respiratory chain 
Various mitochondrial diseases such as 
LHON, MELAS and Leigh syndrome 
Complex II Complex II of 
respiratory chain 
Tumor suppressor 
XPD  Fe-S protein involved 
in nucleotide excision 
repair 
Xeroderma pigmentosum, Cockayne 
syndrome, trichothiodystrophy 
FANCJ Fe-S protein involved 
in nucleotide excision 
repair 
Fanconi anaemia 
MUTYH Fe-S 
protein(glycosylase) 
involved in DNA 
repair 
Colon cancer 
Table 1: Diseases associated with Iron-sulfur cluster biogenesis and Fe-S 
proteins 
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biogenesis pathways. In prokaryotes, the pathways are distinguished based on 
functional significance into the Isc (Iron sulfur cluster) system, Nif (Nitrogen fixation) 
system and the Suf (Sulfur formation) system. The NIF system is exclusively for iron 
sulfur cluster maturation for the nitogenase enzyme in nitrogen fixing bacteria. The 
SUF system is exhibited under conditions of iron depletion in a cell. The pathway that 
closely resembles the eukaryotic pathways is the ISC pathway. However, the 
phylogenetic distribution of these pathways is complicated.  For example, organisms 
such as Mycobacterium tuberculosis and few archaea, appear to have the Suf system 
alone; whereas, in Escherichia coli the Isc system is more important than the Suf 
system[13]. 
In eukaryotes, however, the pathway is classified into cytosolic and 
mitochondrial based on subcellular compartmentalization. The cytosolic pathway is 
known as the CIA machinery. So far, its mitochondrial counterpart – the ISC 
biogenesis pathway, is regarded as the main pathway for iron sulfur cluster 
biogenesis in eukaryotes. Interestingly, the human mitochondrion that is believed to 
have only 13 mitochondrial proteins[14], imports nuclear proteins for the fulfilment 
of iron sulfur cluster maturation. Figure 1.1 and 1.2 highlight all the key proteins of 
both the eukaryotic pathways.  
Our understanding of all these pathways is very primitive as can be seen from 
the relaxation in classification strategy for prokaryotes and eukaryotes; while the 
former is functionally distinguished, the latter is subcellular distribution-based. [No 
correlation has been postulated between the subcellular occurrence of proteins that 
are benefited from the pathways and the subcellular predominance of the pathways  
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FIGURE 1.1: Key players of the Eukaryotic mitochondrial ISC biogenesis 
pathway  
Iron (red circle) is first transported into the mitochondrion with the help of 
monothiol glutaredoxins and inner membrane transport proteins, Mrs 3-Mrs4. 
This iron is presumably collected by Frataxin which binds to Isu1 in an iron-
dependent manner where its role is either to donate iron or to allosterically 
regulate Nfs/Isd11 activity. Nfs/Isd11 is the sulphur (yellow circle) donor for the 
assembly step. An electron transfer unit comprising ferrerdoxin (Yah1), 
ferredoxin reductase (Arh1) and NAD(P)H is also needed to accomplish Fe-S 
cluster assembly. In the second step, transiently-bound 2Fe-2S cluster is 
removed from Isu1 by a chaperone system of ATP-dependent Hsp70 chaperone 
Ssq1, its co-chaperone Jac1 and nucleotide exchange factor Mge1 and 
transported either by a Grx5-Glutathione complex or by a Ferredoxin complex to 
target apoproteins. In the third step, these 2Fe-2S clusters are differentiated 
into 4Fe-4S clusters with the help of Iba57, Isa1 and Isa2 and supplied to specific 
proteins like Lipoate synthase and Aconitase. Simultaneously, a Fe-S cluster 
intermediate is transported through transporter Atm1 to the cytosol for the CIA 
machinery. The CIA machinery uses 7 proteins to accomplish Fe-S cluster 
biogenesis for some cytosolic and nuclear proteins.   
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FIGURE 1.2: Key players of the eukaryotic CIA machinery and the physical link 
between ISC biogenesis pathway and the CIA machinery 
A Fe-S intermediate from the mitochondria is transported through the ABC 
transporter Atm1 to the cytosol. This step is aided by sulfhydryl oxidase Erv1 
and Glutathione. The source for Fe is still not known. In the first step, Fe-S 
cluster is assembled on the P-loop NTPase complex Cfd1-Nbp35. This 
transiently-bound Fe-S cluster is transferred to specific apoproteins by 
proteins Nar1 and Cia1.   
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Function Bacterial 
NIF 
Bacterial 
SUF 
Bacterial 
ISC 
Mitochondrial 
ISC 
Eukaryotic 
CIA 
Cysteine 
desulphurase, 
sulphur 
donor 
NifS SufS-SufE IscS Nfs1-Isd11 Mitochondrial 
Nfs1-Isd11 
U-type 
scaffold for 
assembly 
NifU (N-
terminal 
domain) 
SufU IscU Isu1 - 
A-type 
scaffold for 
assembly 
IscA SufA IscA, ErpA Isa1, Isa2, 
Iba57?  
- 
NFU-type 
scaffold for 
assembly 
NifU(C-
terminal 
domain 
- NfuA Nfu1 - 
P-loop 
NTPase 
scaffold for 
assembly* 
- - - Ind1? Cfd1-Nbp35 
Electron 
transfer 
NifU(middle 
domain) 
- Fdx Yah1-Arh1 - 
Iron donor - - CyaY Yfh1 - 
Transfer of 
Fe-S cluster 
from scaffold 
to target 
apoproteins 
- SufC? HscA, 
HscB 
Ssq1, Jac1, 
Mge1, Grx5 
Nar1, Cia1 
* - Phosphate-binding-loop Nucleoside triphosphatases 
Table 2: Comparison of prokaryotic and eukaryotic proteins involved in the iron 
sulfur cluster biogenesis pathways 
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themselves.] This permits us to look at the similarities in the proteins involved in 
prokaryotic and eukaryotic ISC biogenesis pathways. Table 2 lists the prokaryotic 
proteins in the pathways and its eukaryotic counterparts. The mitochondrial ISC 
biogenesis pathway in eukaryotes will be the focus of this manuscript. 
1.4 General mechanism of mitochondrial Iron Sulfur Cluster biogenesis 
The eukaryotic mitochondrial iron sulfur cluster biogenesis pathway is called 
the ISC biogenesis pathway. The pathway takes place in the mitochondrial matrix 
and is understood in three major steps – iron-sulfur cluster assembly, iron-sulfur 
cluster transfer and iron-sulfur cluster delivery. Seventeen proteins have been 
identified so far in this pathway [15] and a detailed account of the general 
mechanism of the pathway is required for further discussion. The steps involved are 
outlined below. 
Firstly, Cysteine desulfurase and its accessory protein, Isd11, in a PLP-
dependent mechanism, deliver sulfur to a scaffold protein, Isu1. Simulatenously, iron 
loaded-Frataxin is believed to deliver iron to the same scaffold protein. It is not yet 
known whether sulfur delivery or iron delivery is the rate-limiting step in iron-sulfur 
cluster assembly [16]. Once the precursors arrive at Isu1 and are brought into each 
other’s vicinity, through elegant conformational changes of the entire Cysteine 
desulfurase-Isd11-Isu1-Frataxin complex, the genesis of 2Fe-2S clusters occurs. 
These events involved in the formation of a 2Fe-2S cluster, also known as ‘iron-sulfur 
cluster assembly’ constitute the first step of the pathway.  
After assembly of 2Fe-2S clusters on Isu1, these clusters that are transiently 
bound to Isu1 are first removed, then transported and finally, assembled on target 
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apoproteins by Cluster Transfer Proteins. Although these three partial steps are 
difficult to isolate experimentally, iron-sulfur cluster dissociation from Isu1 is 
believed to occur through the ATP-hydrolysis dependent complexation of an ATPase 
chaperone, Ssq1 and its co-chaperone Jac1 on the PVK domain of Isu1[1]. The rate-
limiting step in the entire pathway is believed to be the cluster transfer step from 
IscU (bacterial homolog of Isu1) [17]. Apart from these three steps, there is an 
additional step when some of these 2Fe-2S clusters are differentiated into 4Fe-4S 
clusters for specific apoproteins. Isa1, Isa2 and Iba57 are few proteins involved in 
this additional step[1]. This entire event is broadly categorized as the second major 
step – the ‘iron-sulfur cluster transfer’ step.  
In the final step, iron-sulfur cluster-bound proteins are transported outside 
the mitochondria with the help of ATP transporters and other proteins. Also, some 
Fe-S cluster intermediate alone is believed to be transported outside the 
mitochondria probably, to aid the cytosolic pathway.   
1.5 The organic half of the pathway – Sulfur delivery 
Bacterial NifS was the first protein of the ISC biogenesis pathway that was 
identified and biochemically characterized[13]. Subsequently, two other cysteine 
desulfurases IscS and SufS were discovered. All three proteins are similar in 
sequence and structure and follow a similar persulfide formation strategy to extract 
sulfur [13]. Biochemical studies suggest that their eukaryotic homologs like Nfs1 
(yeast), NFS1 (human-mitochondrial) and ISCS (human-cytosolic) also follow a similar 
strategy. Figure 1.3 shows the crystal structure of bacterial IscS. Some significant 
facts derived from the crystal structure of bacterial IscS are [18]: 
1. L-Cysteine is its reactive substrate. 
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2. They are homodimers with a Pyridoxal-5’ phosphate (PLP) group attached at 
the dimer interface.  
3. Each monomer has two domains. The larger domain has the conserved active 
site lysine residue and the smaller C-terminal domain houses a reactive 
cysteine residue. 
4. The reactive cysteine is easily blocked by alkylating agents like N-ethyl 
maleimide (NEM) and this renders the enzyme inactive.  
5. Substitution of this reactive cysteine by alanine also renders this enzyme 
inactive.  
The general steps involved in sulfur delivery by cysteine desulfurase are as 
follows[19]:  
1. First, PLP binds to an active site, lysine rearranges and forms a ketimine 
adduct with the substrate L-cysteine. 
2. Next, the thiolate group of the reactive cysteine residue in the smaller C-
terminal flexible loop of the enzyme attacks the PLP-bound cysteine by 
nucleophile chemistry.   
3. A series of bond shifts between the reactive cysteine residue and the PLP-
cysteine adduct leads to the extraction of the thiolate group of the substrate 
by the reactive cysteine to form an enzyme-bound persulfide intermediate.  
4. The substrate cysteine devoid of its SH group results in the formation of an 
alanine-PLP adduct.  
5. The mechanism by which alanine is released from PLP is not known yet.  
6. Once persulfide is formed, the proximal sulfur/sulfide group is transferred to 
conserved cysteine residues on Isu1.   
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7. Latest evidence shows that this transfer of persulfide to Isu1 occurs only in 
the presence of iron and nucleotides like ATP and GTP[20]. 
8. The mechanism of this PLP-mediated sulfur extraction reaction of cysteine 
desulfurase is called beta-elimination. 
9. Lastly, the eukaryotic homolog of this enzyme is inactive in the absence of an 
accessory protein named Isd11. 
1.6 Other roles of cysteine desulfurase and subcellular distribution 
Apparently, cysteine desulfurase is not an enzyme used exclusively by the 
cytosol or mitochondria for Iron sulfur cluster biogenesis. The enzyme is also found 
to play a major role in tRNA thiolation [21]. Moreover, it is involved in the 
biosynthesis of major cellular cofactors like thiamin, biotin, lipoic acid and 
molybdenum cofactor[1]. These additional attributes can be considered as the 
enzyme’s moonlighting functions in other cellular processes[1]. Thus, a defect in 
cysteine desulfurase can have a major impact on multiple pathways within a cell. An 
alternative viewpoint that was suggested previously was that cysteine desulfurase 
plays a major role in intracellular sulfur trafficking[13].  
With their involvement in multiple cellular processes it would be reasonable 
to assume that this enzyme is present in all three compartments of the cell – the 
cytosol, the nucleus and the mitochondrion. Although in humans this is the case, in 
yeast, the enzyme is found only in the mitochondria and is believed to shuttle 
between the cytosol and mitochondria for their respective iron sulfur cluster 
biogenesis pathways[22]. This could possibly mean that in higher eukaryotes the 
enzyme is more widespread as opposed to the lower eukaryotes like yeast. 
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Figure 1.3: Ribbon-shaped diagram showing the Crystal structure of IscS  
The diagram shows the dimeric subunits of cysteine desulfurase with an 
active site PLP (pyridoxal 5’ phosphate) at its dimeric interface.  Figure taken 
from [18] 
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1.7 Cysteine desulfurase’s accessory protein - Isd11 and other LYR proteins 
The only major anomaly in the assembly step of eukaryotic Fe-S cluster 
biogenesis pathways is the presence of an 11kDa protein named Isd11. Isd11 is 
found exclusively in eukaryotes [23] and is an ancient protein. Homologs are found in 
the mitosomes of Microsporidia and the hydrogenosomes of Trichomonads, which 
are organelles that originated before the mitochondrion[11]. Different experimental 
approaches on cell viability have suggested that yeast Isd11 is a strictly essential 
protein for the cell [23]. Hence, Isd11 belongs to the small fraction (18%) of cellular 
proteins that are strictly essential for yeast cell viability [24]. The reason for its 
indispensable role in the cell can be attributed to its association with cysteine 
desulfurase and its unique ability to activate the protein. Latest evidence suggests 
that persulfide formation in the active site of cysteine desulfurase occurs only in the 
presence of Isd11 [25]. This is one of the main features that distinguishes eukaryotic 
iron sulfur cluster assembly from its prokaryotic counterpart. 
Although Isd11 has no mitochondrial signal sequence, it exists primarily in the 
mitochondrial matrix and is loosely connected with the inner membrane [23]. Recent 
evidence suggests that a nuclear version of the protein also exists, consistent with 
the subcellular distribution of cysteine desulfurase [26]. This finding is consistent 
with the observation that Isd11 is essential for the biogenesis of mitochondrial and 
nuclear Fe-S clusters [23], although its involvement in cytosolic Fe-S cluster 
formation still needs to be addressed.  
A notable feature of Isd11 is that it belongs to the poorly conserved LYR 
family of proteins [27]. Interestingly, a common functional trait for this family of 
proteins has not been found yet [23]. Other members of this family of proteins 
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include Mzm1, SDHAF1 (Respiratory Complex II subunit), NDUFA6 (Respiratory 
Complex I subunit) and NDUFB9 (Respiratory Complex I subunit). The functional 
significance of few of these LYR proteins like Mzm1, SDHAF1, NDUFA6 and NDUFB9 
suggest that the LYR motif and Fe/S cluster metabolism have some correlation. 
1.8 Cysteine desulfurase – Isd11 complex 
Some information on the Isd11-Nfs complex is available today. Co-
purification of the complex using size-exclusion chromatography has shown that it 
exists as a 180-200kDa protein complex [27]. In-vivo studies have shown that Isd11 
binding on cysteine desulfurase is independent of substrate cysteine binding [17]. In 
addition, inactivation of cysteine desulfurase by the alkylating agent NEM is not 
possible at low concentrations. The same group also found that the LYR motif of 
Isd11 is essential for Isd11 binding and subsequent activation of cysteine desulfurase 
[17]. Finally, as stated above, recent evidence suggests that Isd11 binding is a 
prerequisite for eukaryotic cysteine desulfurase activity and persulfide formation 
[25].  
A lot has been known in the past six years about the coordinated functioning 
of the Isd11-Nfs complex. Still, a lot of questions remain unanswered. Some of the 
questions are: Why is Isd11 exclusively found in eukaryotes? Why does the 
eukaryotic system need an extra protein for sulfur extraction? What changes occur 
in the Iron sulfur cluster biogenesis pathway if methionine or cysteine is depleted? 
Does Isd11 play a role in other pathways without the involvement of cysteine 
desulfurase? With steady developments in this field every year, we can remain 
hopeful that the entire mechanism will be deciphered to a large extent in the near 
future.    
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Chapter 2 Characterisation of DIsd11 
2.1 Prelude 
Isd11 is a nuclear-encoded, 11kDa mitochondrial protein that localizes in the 
mitochondrial matrix after its biosynthesis [1]. Surprisingly, the protein has no 
mitochondrial targeting sequence and yet, enters the matrix of the organelle [1, 2]. 
Another notable feature of this protein is that it has no cysteines and no tryptophans 
in its protein sequence. This eliminates the possibility of performing a fluorescence 
spectroscopy experiment on this protein. Also, every spectroscopic technique that 
majorly relies on light absorption by the tryptophan residues of proteins to 
quantitatively estimate its biochemical properties would be inaccurate for Isd11. 
However, there are certain intrinsic benefits as well. The lack of cysteine residues in 
the protein eliminates the possibility of a Fe-S cluster binding within it and also, 
allows us to eliminate the empirical errors that can cause unfolding of the protein by 
disulfide bond breakage.  
Isd11 has been found to activate eukaryotic cysteine desulfurase both in vivo 
and in vitro. This was accomplished by A. Dancis et al. and D. Pain et al. [3] through 
two elegant experiments. Before this study, other research groups claimed that 
Isd11 has no effect on cysteine desulfurase activity. However, the activity assay used 
for the earlier claims were highly insensitive as it detected the overall microsulfide 
concentrations in the mitochondria on Isd11 depletion. The basis for following such a 
strategy was that Nfs1 is the only known eukaryotic cysteine desulfurase in the 
mitochondrion [4] and hence, any sulphide produced could be only from cysteine 
desulfurase. When a radioactive assay that specifically detects persulfide formation 
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was developed, these assumptions were proven wrong. In the first experiment, a 
yeast mitochondrion expressing Nfs1p was depleted of Isd11p and tested for 
persulfide formation and later, purified Isd11 was imported into the same depleted 
mitochondrion to test if this effected a change. In the first case, no persulfide 
formed; whereas, in the second case, persulfide appeared and increased in intensity 
over time. To test the same phenomenon in vitro, purified Nfs1p was incubated with 
S35-cysteine and tested with and without Isd11. The results of the in vivo experiment 
correlated with the in vivo experiment. This confirmed that Isd11p is a prerequisite 
for yeast Nfs1p activation and persulfide formation and at the same time was not 
required for binding of substrate cysteine with Nfs1p.   
Biochemical characterization of Isd11 is critical for understanding the 
protein’s activity. Like the experiments discussed above, more biochemical 
experiments are required for further characterization of the protein. Simultaneously, 
it is also important to perform biophysical characterization of Isd11 to predict the 
structure of the protein. Prediction of a protein’s structure is the ultimate milestone 
in understanding a protein’s functionality. Presently, the crystal structure of Isd11 is 
not known. Preliminary biophysical characterization before solving Isd11’s crystal 
structure involves studying the folded state of the protein, its oligomeric properties 
and its thermal stability. To accomplish these tasks, Drosophila melanogaster was 
chosen as a model organism in our lab.  
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2.2 Materials and Methods 
2.2.1. Cloning of DIsd11 
 
  DIsd11 cDNA was obtained in a pFLC1 vector, from the Drosophila Genomic 
Research Center (FlyBase ID: FBcI0223918). DIsd11 cDNA was PCR amplified and sub-
cloned into a pET14b vector (Novagen) which has a (His)6 tag and an Ampicillin 
resistance ‘bla’ gene. The cloned plasmid was amplified by transforming into DH5α 
cloning strain (Invitrogen). The DIsd11 sequence represents 107-385bp of the 
complete 705bp open reading frame. Positive clones were verified by DNA 
sequencing (Genewiz facility). Recombinant plasmid was transformed into BL21 
(DE3)-RIL (Stratagene), BL21 (DE3)–Rossetta (Novagen) and BL21 (DE3) E.coli 
competent cell lines for protein expression.  
2.2.2. Optimization of soluble protein expression 
The cell line with best soluble protein expression was identified as BL21 (DE3) 
by growing at 37°C till an OD of 0.8 and then inducing with 0.4mM IPTG for ca. 2 
hours. The next step was to optimize protein expression in the selected cell line, 
BL21 (DE3). DIsd11 soluble protein expression was optimized by varying IPTG 
concentrations, post-induction time intervals, pre-induction OD and Temperatures. 
Optimum protein expression was obtained when BL21 (DE3) was grown at 37°C till 
an OD of 0.8-0.9 and then induced with 0.2mM IPTG for ca. 2.5 hours before 
harvesting by centrifugation.  
2.2.3. Soluble DIsd11 protein purification 
Protein isolation steps were all performed at 4° C. Cells were resuspended in 
50 mM Na3PO4 (pH 7.4), 300 or 500mM NaCl, 20 mM Imidazole and 5 mM β-Me in 
the presence of Complete EDTA-free Protease inhibitor cocktail (Roche). Cells were 
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then lysed by two passes through a French Press cell at high pressure (1100 psi), and 
centrifuged at high speed (21000 rpm) for 1 hour. Crude soluble fraction was filtered 
(0.20 μm) and loaded onto a HisPur Cobalt column (Thermo Scientific) using an 
Imidazole gradient in the range of 0 – 500 mM (DIsd11 protein elutes between 260 
and 380mM). DIsd11 containing fractions were pooled and concentrated to ca. 1mL 
by centrifugation using 3kDa Molecular Weight Cut Off (MWCO) centricons 
(Millipore) spun at 5000 rpm. The concentrated retentive solution was run over a 
HiLoad 16/10 Superdex 75 size exclusion column (General Electronics) equilibrated 
with 50mM Na3PO4 buffer (pH 7.4), 500 mM NaCl. Following this protocol, DIsd11 
monomer and oligomers were obtained based on SDS-PAGE gel analysis (Bio-Rad). 
The obtained protein concentration was 0.5 – 0.6 mg/mL and could be stored 
anaerobically at -20° C, for several weeks and slight degradation appeared only after 
three months. 
2.2.4. Western Blot using Anti-His antibody and Anti-Isd11 antibody 
The western blot experiment was done over two days. On day 1, protein 
samples were run on SDS-PAGE gels, stained in Coomassie Blue and checked for 
purity of loaded samples. Simultaneously, another gel containing the same protein 
samples was left unstained and blotted on a 0.2μm Nitrocellulose membrane (Bio-
Rad). Blotting was performed in three steps: firstly, the Mini Trans-Blot filter paper 
(Bio-Rad), Mini Trans-Blot filter pads (Bio-Rad), the nitrocellulose membrane and the 
unstained gel were soaked in Transfer Buffer (60.5g Tris base , 288g Glycine, 10g SDS 
dissolved in 2L water and further diluted with 600mL methanol and 2.16L of water) 
for 15 minutes. In the second step, all the above-mentioned blotting components 
were stacked on a gel plate and placed in a plastic cassette with the gel facing the 
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black side of the cassette. After assembly, this cassette was placed inside a plastic gel 
frame with the black side of the cassette facing the black side of the frame. The gel 
frame was then almost completely immersed in Transfer buffer and allowed to run 
at 22V overnight in the cold room. 
On day 2, the transfer cassette was pulled out of the chamber and a Ponceau 
red dye staining of the blotted membrane was performed. This was followed by 
washing the membrane in water and blocking the membrane with blocking buffer [5 
%(w/v) non-fat dry milk dissolved in 1X TBST buffer – 50mM Tris-HCl(pH8.0), 150mM 
NaCl and 0.05% Tween20] for 30 minutes to prevent non-specific binding of the 
primary antibody. The Ponceau staining step was optional and was only used to 
check the proper transfer of proteins to the membrane. The blotted nitrocellulose 
membrane was then incubated in a 1:3000 dilution of primary Anti-His antibody or 
Anti-Isd11 antibody in blocking buffer for 3 hours. After the three-hour incubation 
period, the membrane was washed 3 times with 1X TBST buffer. After this step, the 
membrane was incubated in a 1:5000 dilution of secondary antibody in blocking 
buffer (Non-fat dry milk dissolved in 1X TBST) for 1 hour. Following secondary 
antibody incubation, the membrane was again washed 3 times with 1X TBST buffer. 
The membrane was developed using a mixture of Luminol and Peroxidase (1ml each 
for 1min.) and analysed using a CCD camera. 
2.2.5. Circular Dichroism of DIsd11 oligomer-monomer mixture    
Purified DIsd11 protein was completely dialysed into degassed 1mM NaPO4. 
Protein concentration was estimated using Advanced Protein Assay and Lowry Assay. 
The dialysed protein was then degassed for 15 minutes using a Thermovac degassing 
system. A Camphor Sulfonic acid control was performed to check the proper 
25 
 
 
functioning of the UV lamp of the Applied Photophysics CD instrument. After testing 
the lamp, a 1mM NaPO4 buffer absorbance spectrum and CD spectrum were taken 
using π*180 software from 340nm to 180nm. Then, six CD spectra of the DIsd11 
protein in 1mM NaPO4 buffer were collected using the same program. Each DIsd11 
CD spectrum was buffer-subtracted and the six scans were averaged to obtain an 
averaged CD profile. The resulting profile was smoothed, saved and then processed 
using ProData viewer and CDNN softwares.  
2.3 Results and Discussion 
2.3.1. Cloning of DIsd11  
DIsd11 was successfully cloned into pET14b (Figure 2.1), restriction digested 
after cloning (Figure 2.2) and sequence analysed to confirm the presence of the 
DIsd11 gene in the vector (Figure 2.3). This confirmed that the selected DH5α cloning 
strain transformants and the selected BL21(DE3) expression strain transformants had 
the right clone.  
2.3.2. Optimization of soluble protein expression 
The purified plasmid was transformed into three expression strains – 
BL21(DE3), BL21(DE3)-RIL and BL21(DE3)-Rossetta (Figure 2.4). The protein 
expression from BL21(DE3) alone was optimal. Hence, BL21(DE3) was used for 
subsequent expression tests. After a series of expression tests it was found that 
soluble DIsd11 is obtained in high yields when BL21(DE3) is grown at 37ᵒC at a pre-
induction OD of 0.8-0.9 and induced with 0.2mM IPTG for 2 hours (Figure 2.5). Figure 
2.6 shows a flowchart for all the expression conditions tried out. The condition for 
best soluble protein expression was used for large scale protein expression and  
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Figure 2.1: Restriction site map of vector pET14b 
The vector has an Ampicillin resistance gene and a (His)6 tag 
that attaches to the N-terminus of any protein expressed from 
the gene inserted into its Multiple Cloning Site. 
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 Lanes            1                      2                    3                     4       
         Marker           DIsd11           DIsd11           DIsd11 
Figure 2.2: Agarose gel showing the DIsd11 gene after cloning into pET14b 
vector 
A Restriction digestion analysis of the newly cloned pET14b was done to see if 
the DIsd11 gene was correctly inserted into the vector. Lanes 2 and 4 show that 
in colonies 1 and 3 the DIsd11 gene was cloned into the vector. Lane 3 shows 
that in colony 2, DIsd11 gene was not cloned into the vector. 
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Figure 2.3: Protein sequence alignment of DIsd11 with the protein sequence 
available on Pubmed 
The DIsd11 gene was sent to the Genewiz facility for sequence verification. The 
obtained gene sequence was translated into its protein sequence using the 
Expasy translate program and aligned with the available Pubmed protein 
sequence for DIsd11 (RE5789) using the ClustalW2 program. The sequence 
alignment shows 100% identity. 
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Lanes     1        2        3         4         5        6         7        8       9       10      11       12       13 
Figure 2.4: SDS-PAGE gel showing DIsd11 protein expression after transforming 
into three different E.coli strains 
The newly cloned DIsd11 gene was transformed into three E.coli strains – 
BL21(DE3) RIL, BL21(DE3) Rossetta and BL21(DE3). ‘P’ stands for Pre-induced and 
‘I’ stands for Induced. Lanes 2-11 are Pre-induced and Induced samples for 
DIsd11-transformed BL21(DE3)-Rossetta strain. Lanes 12 and 13 are Pre-induced 
and Induced samples for DIsd11-transformed BL21(DE3) strain.  
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Lanes      1           2            3          4          5          6          7           8          9         10      11       
Figure 2.5: Optimization of soluble DIsd11 protein expression 
DIsd11 was best expressed at 0.2mM IPTG, 0.9OD, 37ᵒC, 2 hours. Lanes 2-5 
correspond to samples from the best expressed condition. Lane 4 shows best 
soluble protein expression. ‘PI’ – Pre-induced, ‘I’ - Induced, ‘S’ – Supernatant and ‘P’ 
– Pellet.  
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   Variable:       IPTG        Temperature               Time                   OD 
Figure 2.6: Flowchart of different expression conditions for DIsd11 
protein expression in BL21(DE3) 
The boxes marked in red highlight the condition for best soluble protein 
expression.  
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harvesting. A vital point to be noted is that in every SDS-PAGE gel the Isd11 
monomer ran at ~15kDa instead of 13.5kDa (with the tag). This was confirmed by 
comparing the target samples with the induced samples of Isd11. 
2.3.3. Protein purification of soluble DIsd11 
Protein purification was the next step and after two rounds of purification 
through HisPur Cobalt and HiLoad 16/10 Superdex 75 columns, DIsd11 monomer 
could not be isolated. The protein consistently eluted out with four other proteins of 
higher molecular weights (Figures 2.7). On increasing the pH to 9.14 there seemed to 
be no difference in the purity of the protein (Figures 2.8). Multiple other strategies 
were adopted for solving the problem of co-elution. In one strategy, a nutrient-rich 
growth medium, Terrific broth (Mo Bio Laboratories) was used for cell growth. 
Although the overall soluble protein expression was high, the co-eluted proteins 
could not be separated effectively (Figure 2.9). There appeared to be some DIsd11 
monomer, but this was not sufficient for the proposed experiments. The co-eluted 
proteins were assumed to be oligomers of DIsd11 monomer because literature 
suggests that Isd11 has a tendency to exist as oligomers with cysteine desulfurase in 
the cell. In a second strategy, the purified protein was dialysed using a Micro Bio-spin 
6 column into 7 different co-solvents, each of which was dissolved in a 1mM ZnSO4, 
50mM Tris-HCl (pH 8.0) and 150mM KCl buffer. The co-solvents used were 1M Urea, 
10mM DTT, 1%TFA, 1M Cysteine, 10%DMSO, 40%Methanol, 5% α-D-glucose (Table 
3). None of the samples showed a significant difference suggesting that the 
supposed oligomers were probably not reversible after purification (Figure 2.10). 
However, a limitation to this conclusion could be that Zinc was a constituent of the  
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   A.            B.  
Lanes  1      2       3      4      5      6      7         Lanes     1       2        3         4       5       6   
Figure 2.7: Soluble DIsd11 protein purification using His-Co column affinity 
chromatography and S75 Size-exclusion chromatography at pH 7.4 
In Figure A., lanes 2-7 correspond to different fractions from His-Co affinity 
chromatography purification at a pH of 7.4. Lanes 3, 4 and 5 show that the DIsd11 
monomer protein co-eluted with four other proteins after His-Co affinity 
chromatography between a gradient of 296mM and 386mM Imidazole. Lanes  3-7 
were concentrated and loaded onto an S75 size-exclusion chromatography column.  
In Figure B., lanes 2-6 correspond to serially diluted fractions of DIsd11 protein after 
S75 size-exclusion chromatography. Lane 2 is a highly concentrated DIsd11 protein. 
Lanes 3-6 are serially diluted fractions of the Lane 2 sample. 
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    A.            B.   
Lanes   1  2  3 4  5  6  7 8  9 10 11 12  13   Lanes   1    2    3  4    5   6    7  8   9 
Figure 2.8: Soluble DIsd11 protein purification using His-Co column affinity 
chromatography and S75 Size-exclusion chromatography at pH 
9.14 
In Figure A., lanes 2-14 correspond to different fractions from His-Co affinity 
chromatography purification at a pH of 9.14. As shown in lanes 9-14, DIsd11 
monomer protein primarily co-eluted with two other proteins after His-Co 
affinity chromatography between a gradient of 110mM and 373mM 
Imidazole. Lanes 9-14 and lanes 7-8 were separately concentrated and loaded 
onto an S75 size-exclusion chromatography column.  
In Figure B., lanes 2-9 correspond to serially diluted fractions of DIsd11 
protein after S75 size-exclusion chromatography. Lanes 2 and 6 correspond to 
highly concentrated DIsd11 protein. Lanes 3-5 are serially diluted fractions of 
the Lane 2 sample. Lanes 7-9 are serially diluted fractions of the Lane 6 
sample. 
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A.         B.  
   Lanes     1       2   3    4     5     6     7     Lanes   1     2    3    4     5    6    7    8 
Figure 2.9: Terrific broth-grown soluble DIsd11 protein purification using His-Co 
column affinity chromatography and S75 Size-exclusion 
chromatography 
In Figure A. lanes 2-7 correspond to different fractions from His-Cobalt affinity 
chromatography purification. In lanes 5, 6 and 7, DIsd11 monomer co-elutes with a 
lesser amount of the other higher molecular weight proteins. There also appears to 
be some degradation of DIsd11 monomer. Lanes 4-7 were concentrated and loaded 
on a Sephadex 75 column to see if the higher molecular weight bands can be 
separated.  
In Figure B. lanes 2-8 correspond to different fractions from Sephadex 75 column 
chromatography purification. In lanes 7 and 8, ca. 80% pure DIsd11 monomer could 
be recovered. However, this was not sufficient for the proposed experiments.  
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     A.        B.  
Lanes  1    2    3   4   5   6    7   8   9  10   Lanes  1   2   3   4   5   6    7  8   9  10 
Figure 2.10: Effect of co-solvents on DIsd11 oligomeric state after two rounds of 
purification 
In Figure A. lanes 2-10 correspond to different fractions dialysed into buffer 
containing various co-solvents. Lanes 2-10 are also labelled A-I on the top of the 
gel, where each letter corresponds to the co-solvent used as shown in Table 5. No 
major difference was seen in the supposed oligomeric state of the protein.  
In Figure B. lanes 2-10 correspond to different fractions dialysed into buffer 
containing various co-solvents that were loaded on an SDS-PAGE gel after 48 hours 
of incubation at 4ᵒC. 
 
37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Buffer  Co-solvent   
50mM Tris-HCl, pH 8.0, 
1mM ZnSO4, 100mM 
KCl    
A  5M Urea (Denaturant)  
B  10mM DTT (Reducing agent)  
C  1% TFA (Stabilizes α helices)  
D  1M Cys (DNfs Reaction substrate)  
E  10% DMSO (Denaturant)  
F  40% Methanol (Salting out)  
G  5% Glucose (Reduces aggregation)  
H  Control  
Table 3: Co-solvent categorization for oligomer stability experiment 
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buffer. Many Fe-S cluster assembly proteins are known to bind to Zinc and if this 
happens with Isd11 as well, the oligomer stability maybe increased by Zinc. 
2.3.4. Western Blot using Anti-His antibody and Anti-Isd11 antibody 
The purification results hinted at the immediate need for a Western blot of 
the purified Isd11 protein fractions. Two blotting experiments were performed. In 
the first experiment, an anti-His primary antibody was used and in the second 
experiment, an anti-Isd11 primary antibody was used. The rationale for performing 
two blots was preceded by our hypothesis that the four proteins that co-eluted 
could be oligomers of Isd11 and that if oligomerized, the His-tag maybe difficult to 
detect by the primary anti-His antibody. The anti-His blot revealed only the 
monomer of Isd11. However, the anti-Isd11 blot revealed all four co-eluted proteins 
in addition to the monomer of Isd11 (Figure 2.11). This confirmed our hypothesis 
that the co-eluted proteins are indeed, oligomers of Isd11. However, an alternative 
explanation could also mean that the four proteins are cross-reactive proteins of the 
anti-Isd11 polyclonal primary antibody. 
2.3.5. Circular Dichroism of DIsd11 oligomer-monomer mixture 
Once the identity of the purified Isd11 fraction was confirmed, our next aim 
was to characterize the folded state of the protein. The averaged CD spectra from 
340nm to 180nm (Figure 2.12) suggested that the protein was primarily alpha-helical 
in nature (Table 4). However, the saturation of the UV lamp at the end of 180nm 
slightly distorted the values to favour beta strands over alpha-helices. This could be 
rectified if the saturation can be avoided by identifying the right protein 
concentration. Another variable associated with the performed experiment was that  
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      A.                                                    B.       
Lanes           1             2                                   Lanes       1                2 
        C.                                                   D.  
Lanes           1               2                                                     Lanes       1              2 
Figure 2.11: Western Blot film and SDS-PAGE gel showing presence of 
oligomers in DIsd11 purified fractions 
Figure A. is the Anti-His antibody-tagged Western Blot for the purified DIsd11 
protein. Figure B. is the Anti-Isd11 antibody-tagged Western Blot for the 
purified DIsd11 protein.  
Figure C. is the SDS-PAGE gel corresponding to the Anti-His antibody-tagged 
Western Blot. Figure D. is the SDS-PAGE gel corresponding to the Anti-Isd11 
antibody-tagged Western Blot.  
In all figures, lane 1 is the marker and lane 2 is the DIsd11 protein sample.  
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                                                               A.     
                                                       Lanes         1           2      3 
                   B.   
Figure 2.12: SDS-PAGE gel and CD spectrum of DIsd11 oligomer and 
monomer protein mixture 
In Figure A. Lane 2 corresponds to Pre-S75 DIsd11 sample and Lane 3 
corresponds to the protein used for the Circular Dichroism experiment. 
Figure B. is the averaged CD spectrum of the DIsd11 protein mixture.  
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Secondary structure 190-260nm Standard deviation 
α helices 19 % 2 % 
Antiparallel β 24 % 1 % 
Parallel β 9 % 1 % 
β-turn 17 % 1 % 
Random coil 31 % 1 % 
Table 4: Secondary structure content of DIsd11 protein oligomer-monomer     
mixture  
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the profile reflects only the folded state of the protein mixture and not the folded 
state of the oligomer or monomer individually. 
2.4 Future directions 
Drosophila Isd11 is an interesting protein that is ca. 40% soluble when grown 
in BL21 (DE3) strains of E.coli cell lines. The soluble protein is however, difficult to 
purify in any one of its oligomeric states. Another notable feature is that the protein 
runs at a molecular weight 4kDa higher than its original molecular weight. This is 
consistent with comparisons to induced samples and also from a western blot 
experiment. This strange trait could be because of zinc binding to the protein or 
some other metabolite from the growth media. None of these possibilities have 
been testified and hence, requires further characterization of the protein.  
The limited purity of one state of the protein also makes it difficult to predict 
the secondary structure of DIsd11 monomer or one oligomer alone using Circular 
dichroism. Although we have not been able to isolate one form of the protein from 
the soluble fraction in our lab, we have been able to purify the monomer of Isd11 
using 8M Urea (data not shown). This rigorous method usually interferes with the 
folded state of the protein. Methods to dialyse out the urea using 3kDa MWCO 
Centricons or 3kDa MWCO Dialysis bags have not been successful. Interestingly, 
dialysis of Urea-purified Isd11 into Urea-free buffer has been successful in the yeast 
system when passed through a desalting column and the protein did not oligomerise 
on Urea removal. A limitation to this method is however, the limited recovery of 
protein as most of the Isd11p (yeast system) precipitates after dialysis. Yet, enough 
protein could be recovered for a Circular dichroism experiment. Nevertheless, Urea-
purified DIsd11 awaits the same desalting buffer-exchange treatment.  
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One useful technique for characterising protein-protein interactions is 
Isothermal Titration Calorimetry (ITC). In one of the several ITC experiments 
performed in our lab using Urea-purified DIsd11 and Urea-purified DNfs, DIsd11 was 
found to interact with DNfs (Drosophila cysteine desulfurase) with μM to nM affinity 
in a two-site binding model (data not shown). It was interesting to see an 
endothermic profile during the binding event. In addition, DIsd11 showed no binding 
if left in Urea for 5-7 days and more. Following ITC, both the proteins were tested 
using a cysteine desulfurase activity assay and this revealed that Urea-purified DNfs 
was inactive. These results hinted at the limited usefulness of Urea-purified DIsd11 
and DNfs for binding characterization and therefore, the ITC experiments were not 
pursued further. If a definitive solution is found to remove Urea from the two 
proteins, there could be some success in following this strategy for binding 
characterization.   
In-vivo studies have not yet revealed the exact binding motif of Isd11 with 
cysteine desulfurase, Isu[5] and Frataxin[6]. In future, experiments should be 
directed towards creating deletion mutants of Isd11 to understand the binding event 
in the Fe-S cluster biogenesis complex. The mystery surrounding the functionality of 
the Isd11 LYR motif could also be resolved.  
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Chapter 3 Characterisation of DNfs 
3.1 Prelude 
Cysteine desulfurase was the first protein identified and characterised in the 
Iron sulphur cluster biogenesis pathway. In every pathway dedicated for iron-sulfur 
cluster biogenesis cysteine desulfurase is a common factor and plays the same vital 
role of providing sulphur equivalents from cysteine. There is no substitute for 
cysteine desulfurase in this pathway and therefore, an abrogation of cysteine 
desulfurase is lethal for cell viability [1]. The enzyme is notated in many ways 
depending on the pathway or cell-type under consideration. For example, the 
enzyme is called NifS (in the NIF pathway), SufS (in the SUF pathway), IscS (in the ISC 
pathway), Nfs1p (in yeast) and NifS (in humans)[2]. For convenience, the enzyme will 
be called Nfs for the rest of the discussion.  
Nfs has been identified in the nucleus, cytosol and mitochondrial matrix. The 
enzyme’s localisation in three distinct parts of a cell is concordant with its functional 
diversity. This ‘moonlighting’ property of the enzyme is witnessed in tRNA thiolation 
and cofactor thiamine biosynthesis[3]. So much has been known about Nfs due to its 
structural characterisation. A crystal structure of the bacterial isoform of the 
enzyme, IscS was determined in 2001[4]. This led to a greater understanding of many 
pathways including the iron-sulfur cluster biogenesis pathway. Structural details 
show that Nfs is a homodimeric, PLP-dependent enzyme and each subunit can be 
divided into a small domain and a large domain. This feature is characteristic of α-
family type IV aminotransferases of PLP-dependent enzymes. The relevant features 
of Nfs with reference to its function are that the large domains of the Nfs dimer 
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house the PLP cofactor at the dimer interface. The PLP cofactor is held in place by 
the formation of an internal aldimine Schiff base with a lysine residue in the active 
site. A reactive cysteine residue present in the small domain of Nfs initiates PLP-
mediated catalysis. However, the cysteine residue and the PLP cofactor are ~17Aᵒ 
apart and require the enzyme to undergo a major conformational change. This is 
believed to occur with the help of a flexible loop that connects the large and small 
domain. The entire reaction is believed to take place in a β-elimination fashion.  
All these facets are true for a prokaryotic system. Although IscS shares a 60% 
sequence identity and an 80% sequence similarity with human NifS[4], it remains to 
be seen whether the eukaryotic enzyme shares structural similarity with its 
prokaryotic isoform. This is important because latest evidence suggests that 
eukaryotic cysteine desulfurase is inactive in the absence of an accessory protein 
named Isd11, found exclusively in eukaryotes [5]. This intriguing attribute 
necessitates biochemical and biophysical characterisation of eukaryotic cysteine 
desulfurase. Drosophila cysteine desulfurase was chosen as a model enzyme for 
eukaryotes in our lab and will be notated as DNfs in the following discussion. 
3.2 Materials and Methods 
3.2.1. Cloning of DNfs 
DNfs cDNA was obtained in a pOT2 vector, from the “Drosophila Genomic 
Research Center” (FlyBase ID: FBgn0032393). The DNfs sequence represents 72bp to 
1457bp of the complete 1533bp open reading frame. The first 102bp of the DNfs 
cDNA were truncated to improve protein expression and solubility. The truncated 
cDNA with 1284bp was PCR amplified, sub-cloned into a pENTR/SD/D-TOPO vector 
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(Invitrogen) and then, recombined into pDest15 and pDest17 vectors (Invitrogen) 
using the Gateway Recombination Cloning technology (Invitrogen). The pDest17 
vector has a (His)6 tag and pDest15 has a GST tag to enhance protein expression and 
purification. The pDest clones were first transformed into DH5α cloning strain 
(Invitrogen) for amplification and later transformed into BL21-AI E.coli competent 
cells. Positive clones were verified by DNA sequencing (Genewiz facility). The 
recombinant plasmid was transformed into BL21-AI (Invitrogen) and BL21 (DE3) 
E.coli competent cell lines for protein expression.  
Alternatively, a DNfs cDNA clone with 1284bp cloned by a previous graduate 
student, Dr. Swati Rawat, was also available. The truncated cDNA was cloned into 
pET151/D-TOPO vector (Invitrogen) and transformed into BL21 (DE3) cell line.  
3.2.2. Optimization of soluble protein expression 
The truncated DNfs protein (Δ1-34 DNfs) was expected to have 429 amino 
acids and a molecular weight of 47.46kDa (minus the expression tag). None of the 
clones created by Gateway Recombination cloning technology could be expressed in 
the transformed BL21 cell lines. The next step was to optimize protein expression 
using the alternative DNfs clone in pET151/D-TOPO vector (Invitrogen). For 
convenience, this clone will be referred to as Δ1-34 DNfs2 for the rest of the 
discussion.  Soluble protein expression from Δ1-34 DNfs2 could not be optimized by 
varying IPTG concentrations, post-induction time intervals, pre-induction OD and 
temperatures. Based on the overall protein expression (despite the fact that the 
yield of soluble protein was extremely low), few conditions could be chosen for large 
scale protein expression and purification. For subsequent Δ1-34 DNfs protein 
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expression, Δ1-34 DNfs2 in BL21 (DE3) was grown at 37°C till an OD of 0.8-0.9 and 
then induced with 0.2mM IPTG for ca. 3-4 hours before harvesting by centrifugation.  
3.2.3. Protein purification of soluble Δ1-34 DNfs2  
Protein isolation steps were all performed at 4° C. Cells were resuspended in 
50 mM Na3PO4 (pH 7.4), 300 or 500mM NaCl, 20 mM Imidazole and 5 mM β-Me in 
the presence of Complete EDTA-free Protease inhibitor cocktail (Roche). A 20μg/mL 
of DNase and 5mM MgCl2 were added before lysis to reduce viscosity of the medium 
at the time of filtration. Cells were then lysed by two passes through a French Press 
cell at high pressure (1100 psi), and centrifuged at high speed (21000 rpm) for 1 
hour. Crude soluble fraction was filtered (0.20 μm) and loaded onto a HisPur Ni-NTA 
column (Thermo Scientific) using an Imidazole gradient in the range of 0 – 500 mM. 
The available soluble Δ1-34 DNfs2 containing fractions were pooled and 
concentrated to ca. 1mL by centrifugation using 10kDa Molecular Weight Cut Off 
(MWCO) centricons (Millipore) spun at 5000 rpm. The concentrated retentive 
solution was run over a HiLoad 16/10 Superdex 75 size exclusion column (General 
Electronics) equilibrated with 50mM Na3PO4 buffer (pH 7.4), 500 mM NaCl. The 
fractions obtained were analysed on 10% or 4-20% SDS-PAGE gels (Bio-Rad).  
3.2.4. Auto-induction protocol for soluble Δ1-34 DNfs2 expression 
For the Auto-induction protocol, fresh media was prepared using 5g 
BactoTryptone, 2.5g Bacto-Yeast extract, 1M MgSO4, 50X 5052 (0.5% Glycerol, 0.05% 
Glucose and 0.2% α-lactose), 20X NPS (0.5M Ammonium sulphate, 1M Potassium 
phosphate dibasic and 1M Sodium phosphate monobasic) and 100mg/mL Ampicillin. 
The medium was inoculated with a starter culture and allowed to grow at 27ᵒC for 
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24 hours. After 24 hours, the cultures were harvested by centrifugation. Protein 
purification was then performed by the already described protocol.  
3.2.5. Double-colony selection for soluble Δ1-34 DNfs2 expression 
The Δ1-34 DNfs2 gene in pET151/D-TOPO was first transformed into 
BL21(DE3) competent cell lines and positive clones were selected. One half of the 
selected colonies were grown at 37ᵒC till an OD of 0.8-0.9 and then induced with 
0.2mM IPTG for ca. 3-4 hours. The other half was then re-plated on a fresh LB agar 
plate coated with Ampicillin. Fresh positive clones were selected and expressed 
again at the above-mentioned conditions.  
3.3 Results 
3.3.1. Cloning of DNfs 
N-terminal truncation of proteins is a common strategy used in labs to 
improve solubility of proteins. Experimental evidence in the yeast model suggests 
that Nfs is insoluble in its native form. Therefore, the same strategy was used for our 
Drosophila model. Using ‘Mitoprot’ software the first 34 amino acids at the N-
terminus were found to be the mitochondrial targeting sequence (MTS) and could be 
safely removed without altering the functionality of the protein. Truncated DNfs (Δ1-
34) was successfully cloned into pENTR/SD/D-TOPO vector, recombined into pDest15 
and pDest17 vectors, restriction digested after cloning and sequence analysed to 
confirm the presence of the gene in the vector (Figure 3.1). The sequence analysis of 
the pDest15 clone required further verification as the T7 forward primer could not 
detect the first part of the gene due to the large GST tag sequence. On sequence 
verification of the gene in pDest17, it was confirmed that the selected DH5α cloning 
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Figure 3.1: Sequence verification of pDest17 Δ1-34 DNfs clone 
‘DNfspmd’ is the DNfs sequence available in Pubmed and ‘Nfsp17C2’ is the 
sequence of the newly cloned DNfs gene. 
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strain transformant and the BL21-AI expression strain transformant had the right 
clone. The pDest17 positive clones were selected and also transformed into 
BL21(DE3) expression strain for protein expression. The Δ1-34 DNfs2 clone was also 
transformed into BL21(DE3) for protein expression. 
3.3.2. Optimization of soluble protein expression 
Different expression conditions were tried and yet, none of the colonies with 
positive clones expressed Δ1-34 DNfs (Figure 3.2). The reason for the lack of protein 
expression could not be tracked. Contrary to these unexpected results, the Δ1-34 
DNfs2 clone was able to express protein in the BL21(DE3) expression strain. 
However, ca. 95% of the protein expressed from BL21(DE3) was insoluble (Figure 
3.3B). The clone was also transformed into BL21(DE3)-RIL and BL21(DE3)-Rossetta 
expression strains; but the results did not vary (Figure 3.3A). Based on overall 
protein expression the Δ1-34 DNfs2 clone in BL21(DE3) was used for subsequent 
large scale protein expression and purification and was grown at 37ᵒC at a pre-
induction OD of 0.8-0.9 and induced with 0.2mM IPTG for 3-4 hours. The protein 
with its His6 tag was expressed at a molecular weight corresponding to ca. 48kDa.  
3.3.3. Protein purification of soluble Δ1-34 DNfs2 
Protein purification was the next step and after two rounds of purification 
through HisPur Ni-NTA and HiLoad 16/10 Superdex 75 columns, no pure protein 
could be isolated. The protein consistently eluted out with ca. 80% of bacterial 
proteins (Figure 3.4). A possible reason for the inability to purify Δ1-34 DNfs2 could 
be the drop of protein pI from 8.40 in its native form to 6.58 in its Δ1-34 truncated 
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      A.        B.  
Lanes  1   2   3    4   5   6   7    8   9   10  11  Lanes  1    2    3     4     5    6    7     8    9 
Figure 3.2: SDS-PAGE gel showing Δ1-34 DNfs expression of pDEST15 and 
pDEST17 clones in BL21(DE3) cell lines 
 Figure A. shows DNfs expression from the pDEST15 clone in a BL21(DE3) cell 
line. Lanes 2-5, 6-8 and 9-11 correspond to different expression conditions. 
Figure B. shows DNfs expression from the pDEST17 clone in a BL21(DE3) cell line. 
Lanes 2-5 and 6-9 correspond to different expression conditions. Both gels 
indicate that there is no protein expression under standard expression 
conditions for both the clones.  
In both figures, ‘PI’ stands for Pre-induced, ‘I’ stands for Induced, ‘S’ stands for 
Supernatant and ‘P’ stands for Pellet. 
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    A.          B.    
Lanes   1    2    3     4    5    6    7    8    9        Lanes  1  2   3   4   5  6  7  8  9  10 11 12 13 
Figure 3.3: SDS-PAGE gel showing Δ1-34 DNfs2 protein expression from a 
pET151-D-TOPO clone in BL21(DE3), BL21(DE3)-RIL and 
BL21(DE3)-Rosetta cell lines 
Lanes 2-5 in Figure A. corresponds to Δ1-34 DNfs2 protein expression in 
BL21(DE3)-RIL cell line. Lanes 6-9 in Figure A. corresponds to protein 
expression in BL21(DE3)-Rossetta cell line.  
Lanes 2-13 in Figure B. corresponds to Δ1-34 DNfs2 protein expression in 
BL21(DE3) cell line. 
In both figures, ‘PI’ stands for Pre-induced, ‘I’ stands for Induced, ‘S’ stands 
for Supernatant and ‘P’ stands for Pellet. 
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form. With repeated attempts at large scale protein expression and purification we 
concluded that it was not worth pursuing the large scale expression the truncated 
form of DNfs using conventional strategies.   
3.3.4. Auto-induction for soluble Δ1-34 DNfs2 expression 
The Auto-induction protocol caused lesser bacterial protein expression than 
Δ1-34 DNfs2 (Figure 3.5). This was an improvement from the conventional strategy 
of IPTG-induced expression. However, on lysis and protein purification sufficient 
soluble protein could not be recovered and purified. This suggests that although the 
overall protein expression is high, most of the protein is insoluble. 
3.3.5. Double colony selection for soluble Δ1-34 DNfs2 expression     
By the end of the second round of colony selection and expression, the 
intensity of a lower band ca. 30kDa in size was much more than the first round of 
selection and expression (Figure 3.6). This lower band is speculated to be a 
degradation product of the truncated protein when expressed in BL21(DE3). 
However, this hypothesis can be confirmed only if a Western Blot of the expressed 
protein sample is carried out. 
3.4 Future Directions 
DNfs is an extremely insoluble protein and could not be purified with a 
conventional strategy of IPTG induction or even, auto-induction. 26.4% of amino 
acids in the native state of the protein are positively and negatively charged 
residues. In the truncated form of the protein as well, 26.57% of amino acids are 
positively and negatively charged residues (ExPASy ProtParam program). A key point  
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     A.          B.  
Lanes     1      2    3    4    5    6    7    8     9   10     Lanes    1       2    3      4      5       6       7       8 
Figure 3.4: Soluble Δ1-34 DNfs2 protein purification using His-Co column     
affinity chromatography and S75 Size-exclusion chromatography  
In Figure A., lanes 2-10 (or E1-E9) correspond to different fractions eluted 
from a HisPur Ni-NTA column at a pH of 7.4. Lanes E3-E9 show that the Δ1-34 
DNfs monomer protein (ca. 48kDa with the His tag) was hardly expressed in 
the soluble form and co-eluted with many bacterial proteins after this affinity 
chromatography purification step. Lanes E5-E9 were concentrated and 
loaded onto a HiLoad 16/10 Superdex 75 size-exclusion chromatography 
column.  
In Figure B., lanes 2-10 (or E1-E7) correspond to different fractions from S75 
size-exclusion chromatography. Soluble protein could not be purified even 
after the second stage of purification. 
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A.    B.  
Figure 3.5: Auto-induction of Δ1-34 DNfs2 protein expression 
Figure A. shows Δ1-34 DNfs2 protein expression after induction and at different 
stages of lysis. ‘R’ stands for Resuspension, ‘L’ stands for Lysate, ‘S’ for 
Supernatant and ‘P’ for Pellet. 
Figure B. shows different fractions after His Ni-NTA affinity purification. Two 
bench-type columns were used for this task. A1-A7 represent fractions from one 
column and B1-B5 represent fractions from the second column. So, essentially 
both columns had the same soluble Δ1-34 DNfs2 extract after cell lysis.  
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A.         B.  
Figure 3.6: Δ1-34 DNfs2 protein expression after Double colony selection 
Figure A. shows protein expression after the first round of colony selection. 
Lanes represent protein expression in 5 different colonies. The numbers 
corresponding to each lane represent the colony identity. Figure B. shows 
protein expression after the second round of colony selection. Four colonies 
were selected for protein expression. There was no improvement in protein 
expression. 
In both gels, ‘PI’ stands for Pre-induced and ‘I’ stands for Induced.  
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to be noted is that the theoretical pI of the protein drops from 8.40 in its native state 
to 6.58 in its truncated form. The impact of this change in pI could influence 
solubility. After cloning the truncated form of the gene, one feature was noted on 
close observation. In both the Δ1-34 DNfs-pDest17 clone and the Δ1-34 DNfs2-
pET151/D-TOPO clone, a substitution mutation occurred at exactly one amino acid 
after cloning. In the first clone, the last amino acid histidine was substituted to 
glutamine and in the second clone, the 384th amino acid, arginine was substituted to 
cysteine. It is interesting to see if the mutation occurs due to the genetic machinery 
of the DH5α cloning strain. Whether this single amino acid mutation causes a major 
change in expression and solubility is a question that needs to be addressed.  
The lack of soluble protein expression in few conventional E.coli expression 
systems renders Δ1-34 DNfs2 an unfit clone to work with unless a novel strategy is 
identified. An alternative strategy could involve creating different truncations of the 
gene like Δ1-37 DNfs, Δ1-60DNfs or any other truncation before the 70th amino acid. 
The reason for restricting truncations to the 70th amino acid originates from a 
comparison with the crystal structure of IscS, E.coli cysteine desulfurase. Recent 
evidence in the yeast model suggests that mitochondrial cysteine desulfurase 
undergoes two truncations at its N-terminal sequence by two different processing 
enzymes – MPP (Mitochondrial Processing peptidase) and Icp55[6]. The second 
truncation apparently occurs after the Mitochondrial Targeting Sequence (MTS) is 
cleaved off. The Mitoprot program does not account for the second truncation while 
calculating the MTS. In yeast Nfs1p, Icp55 cleaves off three amino acids after the 
MTS. The same rationale has been used to suggest a Δ1-37 DNfs truncation. 
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Evidence in the human and yeast systems suggest that different isoforms of cysteine 
desulfurase arise from a single transcript by alternative utilisation of in-frame AUGs 
[7]. This means that the mitochondrial and nuclear forms of the protein arise from 
the same transcript. Therefore, creating a Δ1-60DNfs truncation would be another 
useful strategy.  
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Chapter 4 Summary 
4.1 Characterisation of DIsd11 
Drosophila was chosen as our model organism for two main reasons. Firstly, 
many geneticists have used Drosophila to study neurodegenerative disorders and 
the organism seems to be an excellent model for these. Secondly, previous studies in 
our lab with Drosophila proteins like Dfh (Frataxin) and DIsu (Isu homolog), both of 
which are involved in iron-sulphur cluster biogenesis pathway have shown that the 
proteins are more stable when purified. Such a stable system was required for our 
characterisation of Isd11 and Nfs, as proteins that form a complex are known to be 
labile in the absence of its partner. Yeast-based studies have shown signs of 
degradation or aggregation of Nfs in the absence of Isd11, so there is a question of 
extended sample integrity for the yeast proteins. Our first protein characterised in 
this research project was DIsd11.  
DIsd11 could be expressed well in an E.coli expression strain BL21(DE3). The 
solubility of the protein improved only at low IPTG concentrations and could be 
stably expressed at 37ᵒC. The induction time was also lowered to reduce 
precipitation and the insoluble form of the protein. This observation was consistent 
even on a large scale. Once soluble DIsd11 was obtained, the next step was to purify 
the protein, which proved to be a challenging task. Two rounds of purification 
involving His-Co purification in the first step and Superdex 75 Size exclusion 
chromatography in the second step were used, and yet pure protein could not be 
obtained. Several different strategies were adopted and repeated failed attempts 
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suggested to us that we need to perform a Western Blot to identify the nature of the 
rest of the co-eluted proteins. Surprisingly, all the major co-eluted proteins were 
detected on an Anti-Isd11 Western Blot. This gave us increasing confidence to use 
the protein mixture containing possible oligomers and the monomer of DIsd11 for 
Circular Dichroism. However, such a CD experiment could only detect the overall 
secondary structure of DIsd11 and lacked specificity. 
Latest developments in our lab using Desalting columns for buffer-exchange 
have allowed YIsd11 recovery from Urea-solubilised insoluble YIsd11. CD profiles of 
the so-obtained re-folded protein show a high degree of proper folding. This strategy 
needs to be followed in future for proper secondary structure characterisation of 
DIsd11 as well. Interestingly, YIsd11 does not oligomerise on re-folding. Future 
characterisation of the Isd11 protein should focus on the reasons for Isd11 
oligomerisation in vitro. In addition, the function of the LYR motif needs to be 
predicted and also, the exact binding sites of Isd11 on Nfs for cysteine desulfurase 
activity.   
4.2 Characterisation of DNfs 
Simultaneously, DNfs needed to be characterised for any subsequent 
biophysical characterisation of the Cysteine desulfurase complex with Isd11. DNfs 
offered a bigger challenge than DIsd11. The protein showed signs of expression but 
almost 95% of the protein accumulated in the insoluble fraction. Insoluble proteins 
normally assemble in a cell as inclusion bodies and are difficult to re-fold back to the 
native state. However, in a series of purification protocols, DNfs was extracted from 
inclusion bodies using 6 - 8M Urea. All refolding attempts culminated in the 
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precipitation of the protein and loss of activity. So, expression conditions and 
purification protocols had to be designed to produce large amounts of soluble 
protein.  
All proteins targeted for the mitochondria show a high degree of floppiness in 
its N-terminal Mitochondrial Targeting Sequence (MTS) and surprisingly, MTS 
removal is found to improve protein solubility. So, the first 34 amino acids of DNfs 
were removed and the newly cloned gene had only 429 amino acids. Expression 
tests suggested that the protein could be expressed well; but, the issue of solubility 
persisted even after truncation.   
Various expression protocols like the auto-induction protocol and double-
colony selection were performed in addition to the conventional method of IPTG 
induction. None of these protocols showed promising results. With the little protein 
available, protein purification was also tried. Protein solubility tremendously 
influenced the outcome of purification and hence, yielded no pure protein. It 
appears as though the native form of DNfs and its truncated version are poor models 
for DNfs characterisation using E.coli. Site-directed mutagenesis experiments need 
to be performed to recreate the original DNfs gene from the single amino acid 
mutated DNfs clones to verify the above conclusion. If mammalian cell lines or other 
eukaryotic cell lines are not used, DNfs characterisation may continue to pose 
problems in future. However, this does not mean that alternative truncations of the 
protein like Δ1-37 or Δ1-60 DNfs would not improve expression and solubility in 
E.coli. Comparisons with the crystal structure of the bacterial counterpart, IscS allow 
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us to truncate amino acids till the 60th residue without altering the function of the 
protein. Hence, these strategies are also worth exploring.  
4.3 Characterisation of both the proteins 
Simple ITC experiments have been performed in our lab using Urea-purified 
Δ1-34 DNfs2 and DIsd11. One of the trials showed a high endothermic heat 
absorption when Urea-purified DIsd11 was titrated into Urea-purified Δ1-34 DNfs2. 
Unfortunately, these experiments were not pursued further because the enzyme 
appeared to be thoroughly unfolded. A binding event alone was not enough for our 
hypothesis. Our aim was to use the native state of both proteins and predict the 
binding event as well as conformational changes during persulfide formation. The 
results from this strategy would be more conclusive when coupled with the cysteine 
desulfurase activity assay as opposed to using Urea-denatured proteins.   
A simple remedy to the problem of expressing both the proteins separately 
and then allowing complexation would be co-expression of both proteins on one 
vector. This would enable characterisation of the oligomeric state of the Isd11-
cysteine desulfurase complex. Other important features of the entire Iron-sulfur 
cluster assembly complex can also be studied. There are still certain features of the 
complex that can be estimated only if both the proteins are expressed and purified 
individually, unless one figures out how to separate both proteins from the complex. 
One such important study would be an isothermal titration calorimetry experiment 
which estimates the binding affinity of both proteins for each other. This can also 
roughly predict the number of binding sites on Nfs for Isd11. This technique is also 
useful to predict the ability of any of these proteins to bind to metals like zinc or 
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nickel, which is a quality commonly found among proteins involved in Fe-S cluster 
biogenesis.      
Until a crystal structure is obtained, it would be worthwhile trying to predict 
the exact binding motifs within Nfs on which Isd11 monomer units bind. For this 
approach, multiple segments of Nfs will have to be dissected and cloned separately. 
Following this step, protein pull-down assays can be performed to estimate the exact 
binding motif. It is interesting to see where exactly Nfs incorporates Isd11 in its 
dimeric structure because the protein is already known to bind to five other 
proteins.          
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Iron-sulfur clusters are cofactors with evolutionary origins that date back to 
the pre-biotic world. Ever since life originated, these cofactors have intermingled 
with proteins to play vital roles in sustaining life. My research focuses on one such 
protein, the cysteine desulfurase (Nfs) that has the PLP cofactor incorporated in its 
active site and avails of the catalytic property of PLP to provide sulphur for Iron-
sulfur cluster biogenesis and assembly in a cell. Interestingly, in a eukaryotic cell, 
despite the versatility of PLP, cysteine desulfurase’s role as a “sulphur-extractor” is 
incomplete without another protein named Isd11. This interesting piece of evidence 
led us to perform basic protein characterisation of both the proteins so as to 
biophysically study the binding event and conformational changes during persulfide 
formation in future. We chose Drosophila as our model organism. We have been 
able to successfully create a working model for further characterisation of the 
binding event during persulfide formation.  
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